Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ESSA Pharma Inc. | Director | Options | 50K | Mar 25, 2024 | Direct | ||
Carisma Therapeutics Inc. | Director | Stock Option (Right to Buy) | 19.4K | Jun 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CARM | Carisma Therapeutics Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
EPIX | ESSA Pharma Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 28, 2024 | Director |
CARM | Carisma Therapeutics Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
CARM | Carisma Therapeutics Inc. | Mar 7, 2023 | 2 | $0 | 4 | Mar 9, 2023 | Director |
CARM | Carisma Therapeutics Inc. | Mar 7, 2023 | 0 | $0 | 3 | Mar 9, 2023 | Director |
EPIX | ESSA Pharma Inc. | Jun 29, 2022 | 1 | $0 | 4 | Nov 1, 2022 | Director |